Watch the interview!
Disclaimer
This case report and/or content does not reflect the opinion of iHF or iheartfunction.com, nor does it engage their responsibility.
Inotropes in cardiogenic shock: which drug and which dose for which patient?
Coronary artery disease
Interview
Expert insights from Owais Dar and Antoine Kimmoun highlight that dobutamine is the preferred first-line inodilator for cardiogenic shock. Its primary advantage is a 3-minute half-life, offering unmatched bedside flexibility to manage side effects.
Key takeaways:
- Dosing: Start at 2µg/kg/min, titrating to 5µg/kg/min. Avoid exceeding 8µg/kg/min without careful assessment.
- The Diastolic threshold: Monitor Diastolic Blood Pressure (DBP) closely. If DBP < 40 mmHg, initiate Norepinephrine first to restore vascular tone before adding dobutamine to avoid worsening hypotension.
- Safety warning: Dopamine should be avoided. Clinical data (SOAP II trial) associates it with higher arrhythmia rates and increased mortality compared to norepinephrine.
For real-world applications and management protocols, also consult these challenging clinical settings in cardiogenic shock which highlight the necessity of trans-disciplinary care.
